By partnering with industry, government, and the broader community, the School of Biomedical Sciences delivers life-changing research and transfers discoveries into social and medical impacts.
CellaSense is a revolutionary on-demand strategy for therapeutic lead discovery and diversification. Read our showcase case study to find out more.
Bionic array Directed Gene Electrotransfer (BaDGE®) is a novel proprietary technology that enables precision delivery of DNA / RNA therapeutics using an innovative pulsed electric lensing technology.
Dr Emma Sierecki and her team have developed an assay to detection biomarkers for Parkinson’s Disease – alpha-synuclein –in spinal fluid, taking mere hours rather than several days.